Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Molecular Profiling of Cohorts of Tumor Samples to Guide Clinical Development of Pembrolizumab as Monotherapy.

Ayers M, Nebozhyn M, Cristescu R, McClanahan TK, Perini R, Rubin E, Cheng JD, Kaufman DR, Loboda A.

Clin Cancer Res. 2018 Nov 15. doi: 10.1158/1078-0432.CCR-18-1316. [Epub ahead of print]

PMID:
30442684
2.

Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer.

Vaughn DJ, Bellmunt J, Fradet Y, Lee JL, Fong L, Vogelzang NJ, Climent MA, Petrylak DP, Choueiri TK, Necchi A, Gerritsen W, Gurney H, Quinn DI, Culine S, Sternberg CN, Mai Y, Li H, Perini RF, Bajorin DF, de Wit R.

J Clin Oncol. 2018 Jun 1;36(16):1579-1587. doi: 10.1200/JCO.2017.76.9562. Epub 2018 Mar 28.

PMID:
29590008
3.

Pembrolizumab Plus Pegylated Interferon alfa-2b or Ipilimumab for Advanced Melanoma or Renal Cell Carcinoma: Dose-Finding Results from the Phase Ib KEYNOTE-029 Study.

Atkins MB, Hodi FS, Thompson JA, McDermott DF, Hwu WJ, Lawrence DP, Dawson NA, Wong DJ, Bhatia S, James M, Jain L, Robey S, Shu X, Homet Moreno B, Perini RF, Choueiri TK, Ribas A.

Clin Cancer Res. 2018 Apr 15;24(8):1805-1815. doi: 10.1158/1078-0432.CCR-17-3436. Epub 2018 Jan 22.

PMID:
29358500
4.

First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study.

Balar AV, Castellano D, O'Donnell PH, Grivas P, Vuky J, Powles T, Plimack ER, Hahn NM, de Wit R, Pang L, Savage MJ, Perini RF, Keefe SM, Bajorin D, Bellmunt J.

Lancet Oncol. 2017 Nov;18(11):1483-1492. doi: 10.1016/S1470-2045(17)30616-2. Epub 2017 Sep 26.

PMID:
28967485
5.

Heart rate variability in normal-weight patients with polycystic ovary syndrome.

Perini R.

Anatol J Cardiol. 2017 May;17(5):410-411. doi: 10.14744/AnatolJCardiol.2017.24541. No abstract available.

6.

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.

Bellmunt J, de Wit R, Vaughn DJ, Fradet Y, Lee JL, Fong L, Vogelzang NJ, Climent MA, Petrylak DP, Choueiri TK, Necchi A, Gerritsen W, Gurney H, Quinn DI, Culine S, Sternberg CN, Mai Y, Poehlein CH, Perini RF, Bajorin DF; KEYNOTE-045 Investigators.

N Engl J Med. 2017 Mar 16;376(11):1015-1026. doi: 10.1056/NEJMoa1613683. Epub 2017 Feb 17.

7.

Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study.

Plimack ER, Bellmunt J, Gupta S, Berger R, Chow LQ, Juco J, Lunceford J, Saraf S, Perini RF, O'Donnell PH.

Lancet Oncol. 2017 Feb;18(2):212-220. doi: 10.1016/S1470-2045(17)30007-4. Epub 2017 Jan 10.

PMID:
28081914
8.

Acute effects of aerobic exercise promote learning.

Perini R, Bortoletto M, Capogrosso M, Fertonani A, Miniussi C.

Sci Rep. 2016 May 5;6:25440. doi: 10.1038/srep25440.

9.

Palbociclib (PD0332991)-a Selective and Potent Cyclin-Dependent Kinase Inhibitor: A Review of Pharmacodynamics and Clinical Development.

Clark AS, Karasic TB, DeMichele A, Vaughn DJ, O'Hara M, Perini R, Zhang P, Lal P, Feldman M, Gallagher M, O'Dwyer PJ.

JAMA Oncol. 2016 Feb;2(2):253-60. doi: 10.1001/jamaoncol.2015.4701. Review.

PMID:
26633733
10.

Intraparenchymal ventricular diverticula in chronic obstructive hydrocephalus: prevalence, imaging features and evolution.

Manara R, Citton V, Traverso A, Zanotti MC, Faggin R, Sartori S, Perini R, Milanese L, Briani C, Bona F, Rolma G, Rossetto M, Zerbo F, Di Salle F, d'Avella D.

Acta Neurochir (Wien). 2015 Oct;157(10):1721-30. doi: 10.1007/s00701-015-2540-3. Epub 2015 Aug 23.

PMID:
26298592
11.

A beat-by-beat analysis of cardiovascular responses to dry resting and exercise apnoeas in elite divers.

Sivieri A, Fagoni N, Bringard A, Capogrosso M, Perini R, Ferretti G.

Eur J Appl Physiol. 2015 Jan;115(1):119-28. doi: 10.1007/s00421-014-2992-9. Epub 2014 Sep 13.

PMID:
25216993
12.

Clinical utility of integrated positron emission tomography/computed tomography imaging in the clinical management and radiation treatment planning of locally advanced rectal cancer.

Whaley JT, Fernandes AT, Sackmann R, Plastaras JP, Teo BK, Grover S, Perini RF, Metz JM, Pryma DA, Apisarnthanarax S.

Pract Radiat Oncol. 2014 Jul-Aug;4(4):226-32. doi: 10.1016/j.prro.2013.09.002. Epub 2013 Oct 22.

PMID:
25012830
13.

Predicting Outcomes in Locally-Advanced Rectal Cancer Using Pretreatment FDG-PET Imaging.

Fernandes A, Whaley J, Teo K, Plastaras J, Metz J, Perini R, Pryma D, Apisarnthanarax S.

Pract Radiat Oncol. 2013 Apr-Jun;3(2 Suppl 1):S25-6. doi: 10.1016/j.prro.2013.01.089. Epub 2013 Mar 25. No abstract available.

PMID:
24674526
14.

Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer.

Ciunci CA, Perini RF, Avadhani AN, Kang HC, Sun W, Redlinger M, Harlacker K, Flaherty KT, Giantonio BJ, Rosen MA, Divgi CR, Song HK, Englander S, Troxel A, Schnall M, O'Dwyer PJ.

Cancer. 2014 Jan 1;120(1):77-85. doi: 10.1002/cncr.28294. Epub 2013 Sep 24.

15.

Effects of step duration in incremental ramp protocols on peak power and maximal oxygen consumption.

Adami A, Sivieri A, Moia C, Perini R, Ferretti G.

Eur J Appl Physiol. 2013 Oct;113(10):2647-53. doi: 10.1007/s00421-013-2705-9. Epub 2013 Aug 15.

PMID:
23949790
16.

Computed tomography and positron emission tomography/computed tomography surveillance after combined modality treatment of supradiaphragmatic Hodgkin lymphoma: a clinical and economic perspective.

Patel V, Buckstein M, Perini R, Hill-Kayser C, Svoboda J, Plastaras JP.

Leuk Lymphoma. 2013 Oct;54(10):2168-76. doi: 10.3109/10428194.2013.767902. Epub 2013 Feb 12.

PMID:
23331161
17.

The Use of PET in Radiation Therapy for Lymphoma.

Plastaras JP, Geiger G, Perini R, Glatstein E.

PET Clin. 2012 Jan;7(1):67-72. doi: 10.1016/j.cpet.2011.12.005.

PMID:
27157019
18.

A coughing spine.

Norbedo S, Perini R, Amaddeo A.

Emerg Med J. 2012 Jan;29(1):14. doi: 10.1136/emermed-2011-200108. Epub 2011 Jun 21. No abstract available.

PMID:
21693479
19.

Deficient Pms2, ERCC1, Ku86, CcOI in field defects during progression to colon cancer.

Nguyen H, Loustaunau C, Facista A, Ramsey L, Hassounah N, Taylor H, Krouse R, Payne CM, Tsikitis VL, Goldschmid S, Banerjee B, Perini RF, Bernstein C.

J Vis Exp. 2010 Jul 28;(41). pii: 1931. doi: 10.3791/1931.

20.

Cardiovascular time courses during prolonged immersed static apnoea.

Perini R, Gheza A, Moia C, Sponsiello N, Ferretti G.

Eur J Appl Physiol. 2010 Sep;110(2):277-83. doi: 10.1007/s00421-010-1489-4. Epub 2010 May 11.

PMID:
20458594
21.

An analysis of performance in human locomotion.

Ferretti G, Bringard A, Perini R.

Eur J Appl Physiol. 2011 Mar;111(3):391-401. doi: 10.1007/s00421-010-1482-y. Epub 2010 May 1. Review.

PMID:
20437056
22.

Pathogenesis of portal hypertensive gastropathy: translating basic research into clinical practice.

Perini RF, Camara PR, Ferraz JG.

Nat Clin Pract Gastroenterol Hepatol. 2009 Mar;6(3):150-8. doi: 10.1038/ncpgasthep1356. Epub 2009 Feb 3. Review.

PMID:
19190600
23.

Molecular imaging of renal cell carcinoma.

Perini R, Pryma D, Divgi C.

Urol Clin North Am. 2008 Nov;35(4):605-11; vi. doi: 10.1016/j.ucl.2008.07.015. Review.

PMID:
18992614
24.

Changing epidemiology and risk factors for gastrointestinal non-Hodgkin's lymphoma in a North American population: population-based study.

Andrews CN, John Gill M, Urbanski SJ, Stewart D, Perini R, Beck P.

Am J Gastroenterol. 2008 Jul;103(7):1762-9. doi: 10.1111/j.1572-0241.2008.01794.x. Epub 2008 Jun 28.

PMID:
18557717
25.

Inflammatory bowel disease in children and adolescents in Italy: data from the pediatric national IBD register (1996-2003).

Castro M, Papadatou B, Baldassare M, Balli F, Barabino A, Barbera C, Barca S, Barera G, Bascietto F, Berni Canani R, Calacoci M, Campanozzi A, Castellucci G, Catassi C, Colombo M, Covoni MR, Cucchiara S, D'Altilia MR, De Angelis GL, De Virgilis S, Di Ciommo V, Fontana M, Guariso G, Knafelz D, Lambertini A, Licciardi S, Lionetti P, Liotta L, Lombardi G, Maestri L, Martelossi S, Mastella G, Oderda G, Perini R, Pesce F, Ravelli A, Roggero P, Romano C, Rotolo N, Rutigliano V, Scotta S, Sferlazzas C, Staiano A, Ventura A, Zaniboni MG.

Inflamm Bowel Dis. 2008 Sep;14(9):1246-52. doi: 10.1002/ibd.20470.

PMID:
18521916
26.

Non-invasive assessment of tumor neovasculature: techniques and clinical applications.

Perini R, Choe R, Yodh AG, Sehgal C, Divgi CR, Rosen MA.

Cancer Metastasis Rev. 2008 Dec;27(4):615-30. doi: 10.1007/s10555-008-9147-6. Review.

PMID:
18506398
27.

Heart rate and blood pressure time courses during prolonged dry apnoea in breath-hold divers.

Perini R, Tironi A, Gheza A, Butti F, Moia C, Ferretti G.

Eur J Appl Physiol. 2008 Sep;104(1):1-7. doi: 10.1007/s00421-008-0771-1. Epub 2008 May 22.

PMID:
18496707
28.

Age-related decrease in cardiopulmonary adrenergic neuronal function in children as assessed by I-123 metaiodobenzylguanidine imaging.

Chen W, Botvinick EH, Alavi A, Zhang Y, Yang S, Perini R, Zhuang H.

J Nucl Cardiol. 2008 Jan-Feb;15(1):73-9. doi: 10.1016/j.nuclcard.2007.09.027.

PMID:
18242482
29.

Maternal cardiovascular function in pregnancies complicated by intrauterine growth restriction.

Prefumo F, Muiesan ML, Perini R, Paini A, Bonzi B, Lojacono A, Agabiti-Rosei E, Frusca T.

Ultrasound Obstet Gynecol. 2008 Jan;31(1):65-71.

30.

Utility of endoscopic ultrasound, cytology and fluid carcinoembryonic antigen and CA 19-9 levels in pancreatic cystic lesions.

Aljebreen AM, Romagnuolo J, Perini R, Sutherland F.

World J Gastroenterol. 2007 Aug 7;13(29):3962-6.

31.

The aging of the heart and blood vessels: a consideration of anatomy and physiology in the era of computed tomography, magnetic resonance imaging, and positron emission tomographic imaging methods with special consideration of atherogenesis.

Botvinick EH, Perini R, Bural G, Chen W, Chryssikos T, Houseni M, Hernandez-Pampaloni M, Torigian DA, Alavi A.

Semin Nucl Med. 2007 Mar;37(2):120-43. Review.

PMID:
17289459
32.

Seasonal training and heart rate and blood pressure variabilities in young swimmers.

Perini R, Tironi A, Cautero M, Di Nino A, Tam E, Capelli C.

Eur J Appl Physiol. 2006 Jul;97(4):395-403. Epub 2006 Apr 25.

PMID:
16636862
33.

Roles of platelets and proteinase-activated receptors in gastric ulcer healing.

Perini R, Wallace JL, Ma L.

Dig Dis Sci. 2005 Oct;50 Suppl 1:S12-5. Review.

PMID:
16184414
34.

Isolated right segmental hepatic duct injury following laparoscopic cholecystectomy.

Perini RF, Uflacker R, Cunningham JT, Selby JB, Adams D.

Cardiovasc Intervent Radiol. 2005 Mar-Apr;28(2):185-95.

PMID:
15770390
35.

Post-sphincterotomy bleeding after the introduction of microprocessor-controlled electrosurgery: does the new technology make the difference?

Perini RF, Sadurski R, Cotton PB, Patel RS, Hawes RH, Cunningham JT.

Gastrointest Endosc. 2005 Jan;61(1):53-7.

PMID:
15672056
36.

Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets.

Ma L, Perini R, McKnight W, Dicay M, Klein A, Hollenberg MD, Wallace JL.

Proc Natl Acad Sci U S A. 2005 Jan 4;102(1):216-20. Epub 2004 Dec 22.

37.

[Role of Doppler velocimetry of uterine arteries and ambulatory blood pressure monitoring in detecting pregnancies at risk for preeclampsia].

Perini R, Fisogni C, Bonera R, Rovetto B, Frusca T, Lojacono A, Bianchi UA.

Minerva Ginecol. 2004 Apr;56(2):117-23. Italian.

PMID:
15258539
38.
39.

Mucosal repair and COX-2 inhibition.

Perini RF, Ma L, Wallace JL.

Curr Pharm Des. 2003;9(27):2207-11. Review.

PMID:
14529401
40.

Heart rate variability and autonomic activity at rest and during exercise in various physiological conditions.

Perini R, Veicsteinas A.

Eur J Appl Physiol. 2003 Oct;90(3-4):317-25. Epub 2003 Sep 12. Review.

PMID:
13680241
41.

Aerobic training and cardiovascular responses at rest and during exercise in older men and women.

Perini R, Fisher N, Veicsteinas A, Pendergast DR.

Med Sci Sports Exerc. 2002 Apr;34(4):700-8.

PMID:
11932582
42.

The self selected speed of running in recreational long distance runners.

Zamparo P, Perini R, Peano C, di Prampero PE.

Int J Sports Med. 2001 Nov;22(8):598-604.

PMID:
11719896
43.

High prevalence of stress hyperglycaemia in children with febrile seizures and traumatic injuries.

Valerio G, Franzese A, Carlin E, Pecile P, Perini R, Tenore A.

Acta Paediatr. 2001 Jun;90(6):618-22.

PMID:
11440092
44.

Heart rate variability during dynamic exercise in elderly males and females.

Perini R, Milesi S, Fisher NM, Pendergast DR, Veicsteinas A.

Eur J Appl Physiol. 2000 May;82(1-2):8-15.

PMID:
10879437
45.

Bacterial infection in cirrhotic patients and its relationship with alcohol.

Rosa H, Silvério AO, Perini RF, Arruda CB.

Am J Gastroenterol. 2000 May;95(5):1290-3.

PMID:
10811341
46.

Metabolic and cardiorespiratory responses to maximal intermittent knee isokinetic exercise in young healthy humans.

Marzorati M, Perini R, Milesi S, Veicsteinas A.

Eur J Appl Physiol. 2000 Mar;81(4):275-80.

PMID:
10664085
47.

Heart rate variability in exercising humans: effect of water immersion.

Perini R, Milesi S, Biancardi L, Pendergast DR, Veicsteinas A.

Eur J Appl Physiol Occup Physiol. 1998 Mar;77(4):326-32.

PMID:
9562361
48.

c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.

Citro G, D'Agnano I, Leonetti C, Perini R, Bucci B, Zon G, Calabretta B, Zupi G.

Cancer Res. 1998 Jan 15;58(2):283-9.

49.

Effects of high altitude acclimatization on heart rate variability in resting humans.

Perini R, Milesi S, Biancardi L, Veicsteinas A.

Eur J Appl Physiol Occup Physiol. 1996;73(6):521-8.

PMID:
8817122
50.

Multiple elements and auto-repression regulate Rox1, a repressor of hypoxic genes in Saccharomyces cerevisiae.

Deckert J, Perini R, Balasubramanian B, Zitomer RS.

Genetics. 1995 Mar;139(3):1149-58.

Supplemental Content

Loading ...
Support Center